Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Scientific Reports|November 8, 2016
On the behaviour of lung tissue under tension and compressionPinelopi Andrikakou, Karthik Vickraman, Hari Arora
Molecular Therapy. Nucleic Acids|September 24, 2019
Targeted Delivery of C/EBPα-saRNA by RNA Aptamers Shows Anti-tumor Effects in a Mouse Model of Advanced PDACSorah Yoon, Kai-Wen Huang, Pinelopi Andrikakou, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 9, 2017
Development and Mechanism of Small Activating RNA Targeting CEBPA, a Novel Therapeutic in Clinical Trials for Liver CancerJon Voutila, Vikash Reebye, Thomas C Roberts, et al.
Nucleic Acid Therapeutics|July 27, 2022
Enhancing SIRT1 Gene Expression Using Small Activating RNAs: A Novel Approach for Reversing Metabolic SyndromePinelopi Andrikakou, Vikash Reebye, Daniel Vasconcelos, et al.
Oncogene|March 8, 2018
Gene activation of CEBPA using saRNA: preclinical studies of the first in human saRNA drug candidate for liver cancerVikash Reebye, Kai-Wen Huang, Vivian Lin, et al.
Frontiers in Medicine|May 25, 2026
RNA activation as a precision dosing modality: MTL-CEBPA for controlled enzyme elevation in MPS I-HVikash Reebye, Konstantina Skourti-Stathaki, Konstantinos Vanezis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 19, 2021
Upregulation of C/EBPα Inhibits Suppressive Activity of Myeloid Cells and Potentiates Antitumor Response in Mice and Patients with CancerAyumi Hashimoto, Debashis Sarker, Vikash Reebye, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2020
MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-α, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I TrialDebashis Sarker, Ruth Plummer, Tim Meyer, et al.
Pageof 1